- Cardiac Imaging and Diagnostics
- Cardiovascular Disease and Adiposity
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
- Heart Rate Variability and Autonomic Control
- Cardiac Valve Diseases and Treatments
- Blood Pressure and Hypertension Studies
- Pulmonary Hypertension Research and Treatments
- Takotsubo Cardiomyopathy and Associated Phenomena
- Renal and Vascular Pathologies
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Cardiac electrophysiology and arrhythmias
- Antiplatelet Therapy and Cardiovascular Diseases
- Liver Disease Diagnosis and Treatment
- Atrial Fibrillation Management and Outcomes
- Coronary Interventions and Diagnostics
- Thermoregulation and physiological responses
- Cardiovascular and exercise physiology
- Pain Management and Treatment
- Liver Disease and Transplantation
- Cardiac Arrhythmias and Treatments
- Infrared Thermography in Medicine
- Cardiovascular and Diving-Related Complications
- Cardiovascular Issues in Pregnancy
National and Kapodistrian University of Athens
2021-2025
Hippocration General Hospital
2021-2025
Ippokrateio General Hospital of Thessaloniki
2024
Hellenic Air Force
2024
Hellenic Airforce General Hospital
2016
Atrial fibrillation (AF) is a supraventricular arrhythmia and the most common heart rhythm disorder in adult population worldwide with an estimated prevalence of 2% to 4% population. Cases AF have shown increasing trend recent decades, while its frequency expected rise even more. Given significant impact on patients’ quality life, as well major complications -including thromboembolic events- effective control strategies other than antiarrhythmic medication emerged, catheter ablation (CA)...
Background Takotsubo Syndrome (TTS) is an increasingly recognized condition, initially perceived as benign, but now associated with considerable morbidity and mortality. Its pathophysiology remains elusive despite advancements in understanding, management strategies remain inconsistent lack support from randomized clinical trials. Aims This review aims to consolidate current evidence on the pathophysiology, diagnostic algorithms, treatment approaches, prognosis of TTS, while highlighting...
The beneficial cardiovascular effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors irrespective the presence diabetes mellitus are nowadays well established and they already constitute a significant pillar for management heart failure, ejection fraction. exact underlying mechanisms accountable these effects, however, remain largely unknown. direct effect on endothelial function microcirculation is one most studied. broad range studies presented in this review aims to link all...
Abstract Background Right ventricular–pulmonary circulation (RV-PC coupling) serves as an index to evaluate RV function in relation underlying afterload. Although impaired RV-PC coupling has been proposed a predictor of adverse outcomes heart failure (HF) patients with secondary mitral regurgitation (MR), there is limited data available for primary MR and moreover, if sex-related trend. Purpose This study aimed assess at rest during exercise bicycle stress echocardiography asymptomatic...
Abstract Funding Acknowledgements Type of funding sources: None. Background/Introduction Few studies have examined the relationship between exercise and adherence to antihypertensive medication, examining all possible factors contributing blood pressure control. Purpose The purpose our study was access dependence among hypertensive patients visiting Behavioral Cardiology Unit in a Tertiary Hospital. Methods population consisted reporting Hospital during period 6 months 2021. In terms...
We performed a network meta-analysis of randomized controlled trials comparing non-vitamin K antagonist oral anticoagulant (NOAC)-based versus vitamin antagonists (VKA)-based regimens in patients with atrial fibrillation (AF) and acute coronary syndromes or PCI, aiming to examine the precise impact recently established antithrombotic strategies on major bleeding as primary end-point other safety efficacy secondary end-points.